tm logo
OZAPIRA
Dead/Cancelled
CANCELLED - SECTION 8

section 8

on 01 Mar 2024

Last Applicant/ Owned by

86 Morris Avenue

Summit

NJ

07901

Serial Number

86972547 filed on 12th Apr 2016

Registration Number

5263481 registered on 15th Aug 2017

in the Principal Register

Correspondent Address

Marilyn F. Kelly

Bristol-Myers Squibb Company

Trademark Dept., Mailstop D.4243

PO BOX 4000

PRINCETON NJ 08648

Filing Basis

1. intent to use

Disclaimer

NO DATA

OZAPIRA

Pharmaceutical preparations for use in the treatment of leukemia, auto inflammatory disease, autoimmune disease, blood disease, cancer, multiple sclerosis, ulcerative colitis, arthritis, musculoskeletal and skin diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for use in the treatment of leukemia, auto inflammatory disease, autoimmune disease, blood disease, cancer, multiple sclerosis, ulcerative colitis, arthritis, musculoskeletal and skin diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system

Mark Details


Serial Number

No 86972547

Mark Type

No Service/Collective Mark

Attorney Docket Number

No CELG1587US

44D Filed

Yes

44D Current

No

44E filed

Yes

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
01st Mar 2024CANCELLED SEC. 8 (6-YR)
09th Dec 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
09th Dec 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09th Dec 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09th Dec 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
09th Dec 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
09th Dec 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
15th Aug 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
15th Aug 2017REGISTERED-PRINCIPAL REGISTER
30th May 2017PUBLISHED FOR OPPOSITION